This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.

Magaly Rodriguez de Bittner, Viktor V. Chirikov, Ian M. Breunig, Roxanne W. Zaghab, Fadia Tohme Shaya


December 27, 2016
Abt's Ian Bruenig co-authored this article that looks at the effectiveness and cost savings of a real-world, continuous, pharmacist-delivered service with an employed patient population with diabetes over a 5-year period.

The Patients, Pharmacists Partnerships (P3 Program) was offered as an “opt-in” benefit to employees of 6 public and private self-insured employers in Maryland and Virginia. Care was provided in ZIP code–matched locations and at 2 employers' worksites.Six hundred two enrolled patients with type 1 and 2 diabetes were studied between July 2006 and May 2012 with an average follow-up of 2.5 years per patient. Of these patients, 162 had health plan cost and utilization data. A network of 50 trained pharmacists provided chronic disease management to patients with diabetes using a common process of care. Communications were provided to patients and physicians.

The P3 program had positive clinical outcomes and economic outcomes. Pharmacist-provided comprehensive medication therapy management services should be included as a required element of insurance offered by employers and health insurance exchanges.

Access the article here
North America